Home Overview Press Room Blog Publications For Students about us
Search

Medical Gene Transfer : Displaying 86-95 of 206


IngeniousThe EconomistFebruary 8th, 2014It sounds like science fiction, but gene therapy — introducing copies of healthy genes into people who lack them, to treat disease — is looking as if it may become science fact.
Right on target: New era of fast genetic engineeringby Colin BarrasNew ScientistJanuary 27th, 2014If we ever decide to genetically modify people, this is the tool to do it with.
Cloning Fraudster Profiled by Big Science Journalsby Pete ShanksBiopolitical TimesJanuary 19th, 2014Korean stem-cell fraudster Hwang Woo-suk has been busy trying to rehabilitate his reputation and collaborating with the Chinese genomic powerhouse BGI.
Gene doping: Sport's biggest battle? by Tim FranksBBC NewsJanuary 11th, 2014Gene doping may already be happening, but testing authorities are reluctant to discuss the specifics, and some researchers see ethical issues in withholding treatments.
Biopolitical News of the Year 2013by Pete ShanksBiopolitical TimesDecember 19th, 2013For better and worse, 2013 has been a year in which several related issues familiar to those who follow human biotechnology moved into the wider sphere of public discussion.
New Ways to Engineer the Germlineby Jessica CussinsBiopolitical TimesDecember 18th, 2013A look at a number of emerging techniques that could compromise the international consensus against human inheritable genetic modification.
Gene Therapy Scores Big Wins Against Blood CancersUSA TodayDecember 8th, 2013The treatement could become the first gene therapy approved in the United States and the first for cancer worldwide.
Overhaul Recommended for Gene-Therapy Reviewby Erika Check HaydenNatureDecember 5th, 2013A report recommends that the Recombinant DNA Advisory Committee should no longer review most gene-transfer research.
Crispr Goes Commercial by Pete ShanksBiopolitical TimesDecember 5th, 2013A new company, Editas Medicine, has been founded by the scientists who developed Crispr gene-editing technology, with backing from several major venture capital funds.
Cambridge Company Embarks on Genome Engineeringby Callum BorchersThe Boston GlobeNovember 25th, 2013A new life-science company aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue.
Displaying 86-95 of 206  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760